Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells

被引:0
|
作者
Kei Ijichi
Makoto Adachi
Yasuhisa Hasegawa
Tetsuya Ogawa
Hideaki Nakamura
Ayumi Kudoh
Yoshihiro Yasui
Shingo Murakami
Kanji Ishizaki
机构
[1] Aichi Cancer Center Research Institute,Central Laboratory and Radiation Biology
[2] Nagoya City University Graduate School of Medical Sciences,Department of Neuro
[3] Aichi Cancer Center Hospital,Otolaryngology
[4] Aichi Cancer Center Research Institute,Department of Head and Neck Surgery
来源
关键词
HNSCC; Chemotherapy; Cisplatin; 5-FU; Cell cycle;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:745 / 752
页数:7
相关论文
共 50 条
  • [1] Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells
    Ijichi, Kei
    Adachi, Makoto
    Hasegawa, Yasuhisa
    Ogawa, Tetsuya
    Nakamura, Hideaki
    Kudoh, Ayumi
    Yasui, Yoshihiro
    Murakami, Shingo
    Ishizaki, Kanji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 745 - 752
  • [2] A COMPARISON OF CISPLATIN 5-FU WITH CARBOPLATIN 5-FU FOR 5-YEAR SURVIVAL OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    EBELING, O
    ECKEL, HE
    VOLLING, P
    HEITMANN, K
    VOSSING, M
    [J]. HNO, 1994, 42 (10) : 629 - 635
  • [3] CISPLATIN AND 5-FU INFUSIONS IN THERAPY OF ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK IN 50 INDIAN PATIENTS
    SHARMA, SC
    SHARMA, AK
    SINGHAL, KC
    [J]. ACTA PHARMACOLOGICA SINICA, 1990, 11 (03): : 288 - 288
  • [4] A RANDOMIZED TRIAL OF CISPLATIN (CACP) + 5-FLUOROURACIL (5-FU) INFUSION AND CACP + 5-FU BOLUS FOR RECURRENT AND ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    KISH, JA
    ENSLEY, JF
    JACOBS, J
    WEAVER, A
    CUMMINGS, G
    ALSARRAF, M
    [J]. CANCER, 1985, 56 (12) : 2740 - 2744
  • [5] CLINICAL-TRIAL OF CISPLATIN AND 5-FU INFUSION AS INITIAL TREATMENT FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    KISH, J
    DRELICHMAN, A
    JACOBS, J
    HOSCHNER, J
    KINZIE, J
    LOH, J
    WEAVER, A
    ALSARRAF, M
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (03): : 471 - 474
  • [6] Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU (TPF) for the patients with advanced squamous cell carcinoma of the head and neck.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawat, Shin-ichi
    Ikeda, Aya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Continuous infusion of 5-FU with split-dose cisplatin: An effective treatment for advanced squamous-cell carcinoma of the head and neck
    Luo, Zhiguo
    Chang, Jianhua
    Guo, Ye
    Yu, Hui
    Lu, Fangfang
    Wu, Xianghua
    Li, Jin
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE, 2011, 34 (01): : E8 - E13
  • [8] Pre-radiation enhances the cytotoxicity of docetaxel in head and neck squamous cell carcinoma cells
    Furuse, Satori
    Adachi, Makoto
    Ijichi, Kei
    Ohta, Shinsuke
    Torigoe, Soichiro
    Nakazawa, Masatoshi
    Miura, Satoshi
    Mitsudo, Kenji
    Tohnai, Iwai
    [J]. ONCOLOGY REPORTS, 2010, 23 (05) : 1339 - 1343
  • [9] Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma
    Azizzadeh, B
    Yip, HT
    Blackwell, KE
    Horvath, S
    Calcaterra, TC
    Buga, GM
    Ignarro, LJ
    Wang, MB
    [J]. LARYNGOSCOPE, 2001, 111 (11): : 1896 - 1900
  • [10] Cisplatin/5-FU 100/1000 in Japanese Patients With Recurrent/Metastatic SCCHN Management of Recurrent Head-and-Neck Squamous Cell Carcinoma
    Tahara, M.
    Onozawa, Y.
    Fujii, H.
    Monden, N.
    Yana, I.
    Otani, S.
    Hasegawa, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 509 - 510